AbbVie, the maker of the world's best selling drug, reported fourth-quarter profit on Friday that beat Wall Street estimates on strong sales for its blockbuster drug Humira.
Keep Reading →
January 26 - Market Movers, News - Comments
"U.S. stocks pulled back on Tuesday after the S&P 500 and the Nasdaq Composite hit record intraday highs as a decline in healthcare stocks offset gains in technology.
Keep Reading →
May 16 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
"U.S. equities traded mostly lower on Friday as investors digested a tough week for retailers as well as mixed economic data.
Keep Reading →
May 12 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
"U.S. stocks wavered on Wednesday as investors digested a batch of weak corporate earnings and President Donald Trump's dismissal of his FBI chief. At 1:59 p.m.
Keep Reading →
May 10 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
Shares of MannKind Corporation (NASDAQ:MNKD) initially surged sharply higher by over 20% on Friday before pulling back after Bloomberg reported that domestic retail prescriptions...
Keep Reading →
April 7 - Market Movers, News - Comments
"Stocks rose slightly on Friday afternoon as investors parsed through a mixed employment report, a U.S. airstrike in Syria and comments from a top Federal Reserve official.
Keep Reading →
April 7 - Commodities, Gold, Market Movers, News, Tech - Comments
Last week we saw plenty of volatility across the healthcare and biotechnology sectors, driven both by macro and micro factors.
Keep Reading →
March 6 - News, Stock Analysis - Comments
MannKind Corporation (NASDAQ:MNKD) has had a rough time in the market for a couple years at this point, and for good reason.
Keep Reading →
October 14 - News, Stock Analysis - Comments
MannKind Corporation (NASDAQ:MNKD) recently presented data on its inhaled insulin candidate, Afrezza.
Keep Reading →
June 13 - News, Stock Analysis - Comments
U.S. stocks are up for a third consecutive trading session on Tuesday, largely driven by a marked surge in oil prices and a weakening Yen.
Keep Reading →
May 10 - Market Movers, News - Comments
All three major indexes are in the red on Wednesday after Apple Inc. (NASDAQ:AAPL) reported a disappointing quarter.
Keep Reading →
April 27 - Market Movers, News - Comments
With the NASDAQ index in the red and the S&P 500 and Dow Jones Indexes barely in the green, shares of Highpower International Inc (NASDAQ:HPJ), Chesapeake Energy Corporation (...
Keep Reading →
April 12 - Market Movers, News - Comments
The markets are surging on Monday, with all major U.S stock indexes, as well as oil and gold trading up. Of course, not all stocks are benefiting from the overall trend.
Keep Reading →
April 11 - Market Movers, News - Comments
The US Stock Market is quite flattish on Monday, with major indexes posting small gains.
Keep Reading →
March 28 - Market Movers, News - Comments
The stock market is up slightly on Monday, with major U.S stock indexes posting gains of between 0.1% and 0.2%.
Keep Reading →
March 21 - Market Movers, News - Comments
With all three indices in the red today, several stocks opened lower and registered considerable losses in morning trading.
Keep Reading →
January 5 - Market Movers, News - Comments
The decline of the U.S. stocks is continuing for the third day straight, after disappointing economic data put downward pressure on the market.
Keep Reading →
November 13 - Market Movers, News, Tech - Comments
With the broader market down by more than half a percent, shares of International Game Technology Ordinary Shares (NYSE:IGT), Freshpet Inc (NASDAQ:FRPT), Advance Auto Parts, ...
Keep Reading →
November 12 - Market Movers, News - Comments
The US stock market inched down on Tuesday amid concerns regarding the Chinese economy and a coming rate hike.
Keep Reading →
November 10 - Earnings Report, Market Movers, News, Tech - Comments
On a day where the S&P 500 is up by 0.82% and the NASDAQ is up by over 1%, shares of Green Brick Partners Inc (NASDAQ:GRBK), MannKind Corporation (NASDAQ:MNKD), Team Health Holdings...
Keep Reading →
November 2 - Market Movers, News - Comments
Shares of MannKind Corporation (NASDAQ:MNKD) got crushed on Wednesday, ending the day down by 10.07%, on the back of a research note published by Piper Jaffray analyst Joshua ...
Keep Reading →
September 11 - Hedge Funds, News, Stock Analysis - Comments
This article is temporarily removed from Insider Monkey.
Keep Reading →
July 23 - News - Comments
Warren Buffett had plenty of admirers Saturday at the annual meeting of his Berkshire Hathaway Inc. in Omaha, Nebraska.
Keep Reading →
May 7 - Hedge Funds - Comments
MannKind Corporation, focused on discovering, developing and commercializing treatments for diabetes, announced today that it will present at The Morgan Stanley Global Healthcare...
Keep Reading →
September 5 - News - Comments
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Keep Reading →
September 4 - News - Comments
In the eyes of many market players, hedge funds are seen as overrated, old investment tools of a period lost to current times.
Keep Reading →
September 3 - News - Comments
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Keep Reading →
September 3 - News - Comments
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Keep Reading →
August 30 - News - Comments
In the financial world, there are a multitude of gauges investors can use to watch publicly traded companies. A couple of the best are hedge fund and insider trading interest.
Keep Reading →
August 30 - News - Comments
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
Keep Reading →
August 28 - News - Comments
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to track Mr. Market.
Keep Reading →
August 22 - News - Comments
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we've seen from the smart money, out of the entire stock market universe and the 500+ elite...
Keep Reading →
August 22 - News - Comments
The MannKind Corporation has announced that as per the agreement to the 1 July 2013, facility contract, between MNKD and the Deerfield Private Design Fund II.
Keep Reading →
August 20 - News - Comments
MannKind's positive take on interim Phase III data for its inhaled insulin Afrezza has a big sweetener tied to it.
Keep Reading →
August 16 - News - Comments
MannKind Corporation (NASDAQ:MNKD) ended up more than 10% on Wednesday, after the biotech announced positive results for two phase 3 trials testing its inhaled insulin Afrezza...
Keep Reading →
August 15 - News - Comments
The long promise of insulin that diabetics can inhale appears to be moving closer to the market.
Keep Reading →
August 14 - News - Comments
With luck, Santa Clarita’s MannKind Corporation (NASDAQ:MNKD) hopes to have FDA approval by April of next year of its innovative diabetes treatment – Afrezza.
Keep Reading →
August 1 - News - Comments
The share prices of MannKind Corporation (NASDAQ:MNKD) had been traded in the price range of $5.70 and $7.62 per share on Tuesday.
Keep Reading →
June 19 - News - Comments
In the eyes of most traders, hedge funds are seen as worthless, old financial tools of the past.
Keep Reading →
June 10 - News - Comments
If you'd ask most shareholders, hedge funds are assumed to be underperforming, old investment tools of the past.
Keep Reading →
June 3 - News - Comments
An enormous call trade tops today's option activity in biopharmaceutical company MannKind Corporation (NASDAQ:MNKD) as takeover speculation rises.
Keep Reading →
May 22 - News - Comments
According to most investors, hedge funds are perceived as worthless, old financial tools of years past.
Keep Reading →
April 8 - News - Comments
